APA (7th ed.) Citation

Skarbnik, A., Kittai, A., Miranda, M., Yong, A., Roos, J., Hettle, R., . . . Ghia, P. (2023, August). P642: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY AND SAFETY OF ACALABRUTINIB VERSUS ZANUBRUTINIB IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA. HemaSphere.

Chicago Style (17th ed.) Citation

Skarbnik, Alan, Adam Kittai, Miguel Miranda, Alan Yong, Jack Roos, Robert Hettle, Sarah Palazuelos-Munoz, Vikram Shetty, and Paolo Ghia. "P642: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY AND SAFETY OF ACALABRUTINIB VERSUS ZANUBRUTINIB IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA." HemaSphere Aug. 2023.

MLA (9th ed.) Citation

Skarbnik, Alan, et al. "P642: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY AND SAFETY OF ACALABRUTINIB VERSUS ZANUBRUTINIB IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA." HemaSphere, Aug. 2023.